<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Mass effect of <z:mp ids='MP_0008817'>hematoma</z:mp> and the associated perihematomal <z:hpo ids='HP_0000969'>edema</z:hpo> are commonly responsible for neurological deterioration after <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Efficacy of surgical and medical therapy is limited </plain></SENT>
<SENT sid="2" pm="."><plain>We studied the effect of early continuous hypertonic saline infusion on development of perihematomal <z:hpo ids='HP_0000969'>edema</z:hpo> after severe spontaneous supratentorial <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Patients with spontaneous lobar and basal ganglia/thalamic <z:mp ids='MP_0001914'>bleeding</z:mp> &gt;30 mL (n=26) were treated with early (&lt;72 hours) continuous hypertonic saline infusion (3%) to achieve <z:chebi fb="199" ids="26708">sodium</z:chebi> of 145 to 155 mmol/L and osmolality of 310 to 320 mOsmol/kg </plain></SENT>
<SENT sid="4" pm="."><plain>Evolution of absolute <z:hpo ids='HP_0000969'>edema</z:hpo> volume and relative <z:hpo ids='HP_0000969'>edema</z:hpo> volume (ratio absolute <z:hpo ids='HP_0000969'>edema</z:hpo> volume/initial <z:mp ids='MP_0008817'>hematoma</z:mp> volume) was assessed on repeated cranial CT and compared to historical patients (n=64) identified on database with <z:mp ids='MP_0008817'>hematoma</z:mp> &gt;30 mL </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In the treatment group, absolute <z:hpo ids='HP_0000969'>edema</z:hpo> volume was significant smaller between day 8 and day 14 (P(absolute <z:hpo ids='HP_0000969'>edema</z:hpo> volume)= 0.04) and relative <z:hpo ids='HP_0000969'>edema</z:hpo> volume was significant smaller between day 2 and day 14 (P(relative <z:hpo ids='HP_0000969'>edema</z:hpo> volume)=0.02) </plain></SENT>
<SENT sid="6" pm="."><plain>Intracranial pressure crisis (&gt;20 mm Hg for &gt;20 minutes or new <z:hpo ids='HP_0009916'>anisocoria</z:hpo>) occurred less frequently in the treatment group (12 versus 56; P=0.048) </plain></SENT>
<SENT sid="7" pm="."><plain>In-hospital mortality was 3 (11.5%) in the hypertonic saline group and 16 (25%) in the control group (P=0.078) </plain></SENT>
<SENT sid="8" pm="."><plain>Side effects theoretically associated with hypertonic saline including <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> and <z:hpo ids='HP_0011009'>acute</z:hpo> heart and <z:hpo ids='HP_0000083'>renal failure</z:hpo> occurred in both groups to a similar extent </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Early and continuous infusion of hypertonic saline in patients with severe spontaneous <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo> was feasible and safe </plain></SENT>
<SENT sid="10" pm="."><plain>The beneficial effect of this treatment regimen on <z:hpo ids='HP_0000969'>edema</z:hpo> evolution and outcome has to be demonstrated in a controlled trial </plain></SENT>
</text></document>